-
1
-
-
16244414000
-
Docetaxel for treatment of solid tumours: A systematic review of clinical data
-
Montero A, Fossella F, Hortobagyi G, Valero V. Docetaxel for treatment of solid tumours: a systematic review of clinical data. Lancet Oncol. 2005; 6: 229-239.
-
(2005)
Lancet Oncol
, vol.6
, pp. 229-239
-
-
Montero, A.1
Fossella, F.2
Hortobagyi, G.3
Valero, V.4
-
2
-
-
41949114548
-
Taxanes, microtubules and chemoresistant breast cancer
-
McGrogan BT, Gilmartin B, Carney DN, McCann A. Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 2008; 1785: 96-132.
-
(2008)
Biochim. Biophys. Acta
, vol.1785
, pp. 96-132
-
-
McGrogan, B.T.1
Gilmartin, B.2
Carney, D.N.3
McCann, A.4
-
3
-
-
34147191650
-
Telling cells how to die: Docetaxel therapy in cancer cell lines
-
Hernandez-Vargas H, Palacios J, Moreno-Bueno G. Telling cells how to die: docetaxel therapy in cancer cell lines. Cell Cycle 2007; 6: 780-783.
-
(2007)
Cell Cycle
, vol.6
, pp. 780-783
-
-
Hernandez-Vargas, H.1
Palacios, J.2
Moreno-Bueno, G.3
-
4
-
-
27644434717
-
Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells
-
Morse DL, Gray H, Payne CM, Gillies RJ. Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol. Cancer Ther. 2005; 4: 1495-1504.
-
(2005)
Mol. Cancer Ther
, vol.4
, pp. 1495-1504
-
-
Morse, D.L.1
Gray, H.2
Payne, C.M.3
Gillies, R.J.4
-
5
-
-
34247898998
-
Molecular profiling of docetaxel cytotoxicity in breast cancer cells: Uncoupling of aberrant mitosis and apoptosis
-
Hernandez-Vargas H, Palacios J, Moreno-Bueno G. Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis. Oncogene 2007; 26: 2902-2913.
-
(2007)
Oncogene
, vol.26
, pp. 2902-2913
-
-
Hernandez-Vargas, H.1
Palacios, J.2
Moreno-Bueno, G.3
-
6
-
-
33745249512
-
Microtubule-targeting agents in angiogenesis: Where do we stand?
-
Pasquier E, Honore S, Braguer D. Microtubule-targeting agents in angiogenesis: where do we stand? Drug Resist. Updat. 2006; 9: 74-86.
-
(2006)
Drug Resist. Updat
, vol.9
, pp. 74-86
-
-
Pasquier, E.1
Honore, S.2
Braguer, D.3
-
7
-
-
0038105608
-
Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): Association with impaired repositioning of the microtubule organizing center
-
Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol. Cancer Ther. 2002; 1: 1191-1200.
-
(2002)
Mol. Cancer Ther
, vol.1
, pp. 1191-1200
-
-
Hotchkiss, K.A.1
Ashton, A.W.2
Mahmood, R.3
Russell, R.G.4
Sparano, J.A.5
Schwartz, E.L.6
-
9
-
-
65349175232
-
Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer
-
Turnbull LW. Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer. NMR Biomed. 2009; 22: 28-39.
-
(2009)
NMR Biomed
, vol.22
, pp. 28-39
-
-
Turnbull, L.W.1
-
10
-
-
33646148970
-
Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: Initial clinical results
-
Padhani AR, Hayes C, Assersohn L, Powles T, Makris A, Suckling J, Leach MO, Husband JE. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 2006; 239: 361-374.
-
(2006)
Radiology
, vol.239
, pp. 361-374
-
-
Padhani, A.R.1
Hayes, C.2
Assersohn, L.3
Powles, T.4
Makris, A.5
Suckling, J.6
Leach, M.O.7
Husband, J.E.8
-
12
-
-
0036668651
-
High-resolution magic angle spinning MRS of breast cancer tissue
-
Sitter B, Sonnewald U, Spraul M, Fjosne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002; 15: 327-337.
-
(2002)
NMR Biomed
, vol.15
, pp. 327-337
-
-
Sitter, B.1
Sonnewald, U.2
Spraul, M.3
Fjosne, H.E.4
Gribbestad, I.S.5
-
13
-
-
34547961543
-
Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts
-
Morse DL, Raghunand N, Sadarangani P, Murthi S, Job C, Day S, Howison C, Gillies RJ. Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extracts. Magn. Reson. Med. 2007; 58: 270-280.
-
(2007)
Magn. Reson. Med
, vol.58
, pp. 270-280
-
-
Morse, D.L.1
Raghunand, N.2
Sadarangani, P.3
Murthi, S.4
Job, C.5
Day, S.6
Howison, C.7
Gillies, R.J.8
-
14
-
-
20344399898
-
Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: A reference region model
-
Yankeelov TE, Luci JJ, Lepage M, Li R, Debusk L, Lin PC, Price RR, Gore JC. Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn. Reson. Imaging 2005; 23: 519-529.
-
(2005)
Magn. Reson. Imaging
, vol.23
, pp. 519-529
-
-
Yankeelov, T.E.1
Luci, J.J.2
Lepage, M.3
Li, R.4
Debusk, L.5
Lin, P.C.6
Price, R.R.7
Gore, J.C.8
-
15
-
-
0025047826
-
Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors
-
Larsson HB, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn. Reson. Med. 1990; 16: 117-131.
-
(1990)
Magn. Reson. Med
, vol.16
, pp. 117-131
-
-
Larsson, H.B.1
Stubgaard, M.2
Frederiksen, J.L.3
Jensen, M.4
Henriksen, O.5
Paulson, O.B.6
-
16
-
-
0032828135
-
Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: Standardized quantities and symbols
-
Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 1999; 10: 223-232.
-
(1999)
J. Magn. Reson. Imaging
, vol.10
, pp. 223-232
-
-
Tofts, P.S.1
Brix, G.2
Buckley, D.L.3
Evelhoch, J.L.4
Henderson, E.5
Knopp, M.V.6
Larsson, H.B.7
Lee, T.Y.8
Mayr, N.A.9
Parker, G.J.10
Port, R.E.11
Taylor, J.12
Weisskoff, R.M.13
-
17
-
-
42549098548
-
Effect of dietary tetradecylthioacetic acid on colon cancer growth studied by dynamic contrast enhanced MRI
-
Jensen LR, Berge K, Bathen TF, Wergedahl H, Schonberg SA, Bofin A, Berge RK, Gribbestad IS. Effect of dietary tetradecylthioacetic acid on colon cancer growth studied by dynamic contrast enhanced MRI. Cancer Biol. Ther. 2007; 6: 1810-1816.
-
(2007)
Cancer Biol. Ther
, vol.6
, pp. 1810-1816
-
-
Jensen, L.R.1
Berge, K.2
Bathen, T.F.3
Wergedahl, H.4
Schonberg, S.A.5
Bofin, A.6
Berge, R.K.7
Gribbestad, I.S.8
-
19
-
-
34447639457
-
MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status
-
Bathen TF, Jensen LR, Sitter B, Fjosne HE, Halgunset J, Axelson DE, Gribbestad IS, Lundgren S. MR-determined metabolic phenotype of breast cancer in prediction of lymphatic spread, grade, and hormone status. Breast Cancer Res. Treat. 2007; 104: 181-189.
-
(2007)
Breast Cancer Res. Treat
, vol.104
, pp. 181-189
-
-
Bathen, T.F.1
Jensen, L.R.2
Sitter, B.3
Fjosne, H.E.4
Halgunset, J.5
Axelson, D.E.6
Gribbestad, I.S.7
Lundgren, S.8
-
20
-
-
0002269102
-
Introducing basic principles and methods of stereology and morphometry
-
Reith A, Mayhew TM eds, Hemisphere Publishing Corporation: New York
-
Mayhew TM, Reith A. Introducing basic principles and methods of stereology and morphometry. In Stereology and Morphometry in Electron Microscopy: Problems and Solutions, Reith A, Mayhew TM (eds). Hemisphere Publishing Corporation: New York, 1988; 1-12.
-
(1988)
Stereology and Morphometry in Electron Microscopy: Problems and Solutions
, pp. 1-12
-
-
Mayhew, T.M.1
Reith, A.2
-
21
-
-
3543119624
-
Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: A preclinical study of human melanoma xenografts
-
Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts. Magn. Reson. Med. 2004; 52: 269-276.
-
(2004)
Magn. Reson. Med
, vol.52
, pp. 269-276
-
-
Benjaminsen, I.C.1
Graff, B.A.2
Brurberg, K.G.3
Rofstad, E.K.4
-
22
-
-
0033178578
-
Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: Clinical implications
-
Griffon-Etienne G, Boucher Y, Brekken C, Suit HD, Jain RK. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res. 1999; 59: 3776-3782.
-
(1999)
Cancer Res
, vol.59
, pp. 3776-3782
-
-
Griffon-Etienne, G.1
Boucher, Y.2
Brekken, C.3
Suit, H.D.4
Jain, R.K.5
-
23
-
-
0031784409
-
Response of MCF7 human breast cancer to tamoxifen: Evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method
-
Furman-Haran E, Grobgeld D, Margalit R, Degani H. Response of MCF7 human breast cancer to tamoxifen: evaluation by the three-time-point, contrast-enhanced magnetic resonance imaging method. Clin. Cancer Res. 1998; 4: 2299-2304.
-
(1998)
Clin. Cancer Res
, vol.4
, pp. 2299-2304
-
-
Furman-Haran, E.1
Grobgeld, D.2
Margalit, R.3
Degani, H.4
-
24
-
-
11844254414
-
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
-
Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307: 58-62.
-
(2005)
Science
, vol.307
, pp. 58-62
-
-
Jain, R.K.1
-
25
-
-
0035865363
-
Redefining the target: Chemotherapeutics as antiangiogenics
-
Miller KD, Sweeney CJ, Sledge GW ,Jr Redefining the target: chemotherapeutics as antiangiogenics. J. Clin. Oncol. 2001; 19: 1195-1206.
-
(2001)
J. Clin. Oncol
, vol.19
, pp. 1195-1206
-
-
Miller, K.D.1
Sweeney, C.J.2
Sledge Jr, G.W.3
-
26
-
-
34548268026
-
Modelling breast cancer: One size does not fit all
-
Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat. Rev. Cancer 2007; 7: 659-672.
-
(2007)
Nat. Rev. Cancer
, vol.7
, pp. 659-672
-
-
Vargo-Gogola, T.1
Rosen, J.M.2
-
27
-
-
55749092253
-
Effect of Gd-DTPA-BMA on choline signals of HT29 tumors detected by in vivo 1H MRS
-
Madhu B, Robinson SP, Howe FA, Griffiths JR. Effect of Gd-DTPA-BMA on choline signals of HT29 tumors detected by in vivo 1H MRS. J. Magn. Reson. Imaging 2008; 28: 1201-1208.
-
(2008)
J. Magn. Reson. Imaging
, vol.28
, pp. 1201-1208
-
-
Madhu, B.1
Robinson, S.P.2
Howe, F.A.3
Griffiths, J.R.4
-
29
-
-
65349109924
-
Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway
-
Morse DL, Carroll D, Day S, Gray H, Sadarangani P, Murthi S, Job C, Baggett B, Raghunand N, Gillies RJ. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway. NMR Biomed. 2009; 22: 114-127.
-
(2009)
NMR Biomed
, vol.22
, pp. 114-127
-
-
Morse, D.L.1
Carroll, D.2
Day, S.3
Gray, H.4
Sadarangani, P.5
Murthi, S.6
Job, C.7
Baggett, B.8
Raghunand, N.9
Gillies, R.J.10
-
30
-
-
33947127063
-
Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies
-
Eliyahu G, Kreizman T, Degani H. Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies. Int. J. Cancer 2007; 120: 1721-1730.
-
(2007)
Int. J. Cancer
, vol.120
, pp. 1721-1730
-
-
Eliyahu, G.1
Kreizman, T.2
Degani, H.3
-
31
-
-
32844456226
-
Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters
-
Sitter B, Lundgren S, Bathen TF, Halgunset J, Fjosne HE, Gribbestad IS. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters. NMR Biomed. 2006; 19: 30-40.
-
(2006)
NMR Biomed
, vol.19
, pp. 30-40
-
-
Sitter, B.1
Lundgren, S.2
Bathen, T.F.3
Halgunset, J.4
Fjosne, H.E.5
Gribbestad, I.S.6
-
32
-
-
33750435528
-
Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism
-
Glunde K, Serkova NJ. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism. Pharmacogenomics 2006; 7: 1109-1123.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 1109-1123
-
-
Glunde, K.1
Serkova, N.J.2
-
33
-
-
0036089979
-
Docetaxel: Pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model
-
Marchettini P, Stuart OA, Mohamed F, Yoo D, Sugarbaker PH. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Cancer Chemother. Pharmacol. 2002; 49: 499-503.
-
(2002)
Cancer Chemother. Pharmacol
, vol.49
, pp. 499-503
-
-
Marchettini, P.1
Stuart, O.A.2
Mohamed, F.3
Yoo, D.4
Sugarbaker, P.H.5
-
34
-
-
0036097294
-
Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI
-
Jennings D, Hatton BN, Guo J, Galons JP, Trouard TP, Raghunand N, Marshall J, Gillies RJ. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 2002; 4: 255-262.
-
(2002)
Neoplasia
, vol.4
, pp. 255-262
-
-
Jennings, D.1
Hatton, B.N.2
Guo, J.3
Galons, J.P.4
Trouard, T.P.5
Raghunand, N.6
Marshall, J.7
Gillies, R.J.8
|